Anbio Biotechnology (NNNN) Current Assets (2023 - 2025)

Historic Current Assets for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to $27680.6 billion.

  • Anbio Biotechnology's Current Assets changed N/A to $27680.6 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $27680.6 billion, marking a year-over-year change of. This contributed to the annual value of $18534.3 billion for FY2024, which is 11768103170.4% up from last year.
  • Per Anbio Biotechnology's latest filing, its Current Assets stood at $27680.6 billion for Q2 2025.
  • In the past 5 years, Anbio Biotechnology's Current Assets registered a high of $27680.6 billion during Q2 2025, and its lowest value of $15.7 million during Q4 2023.
  • For the 3-year period, Anbio Biotechnology's Current Assets averaged around $15405.0 billion, with its median value being $18534.3 billion (2024).
  • Within the past 5 years, the most significant YoY rise in Anbio Biotechnology's Current Assets was 11768103170.4% (2024), while the steepest drop was 11768103170.4% (2024).
  • Quarter analysis of 3 years shows Anbio Biotechnology's Current Assets stood at $15.7 million in 2023, then surged by 117681031.7% to $18534.3 billion in 2024, then skyrocketed by 49.35% to $27680.6 billion in 2025.
  • Its Current Assets stands at $27680.6 billion for Q2 2025, versus $18534.3 billion for Q4 2024 and $15.7 million for Q4 2023.